MOSCOW (MRC) -- Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has reached agreement with Cathay Investments for the sale of Euroresins, said the company in its press-release.
Subject to customary approvals and notifications, the transaction is expected to close in Q1 2015. Financial details will not be disclosed at this time.
Euroresins is a distributor of products to the composite resins industry with activities in nine countries in Europe, including the United Kingdom, Italy and France. Euroresins realizes sales of approximately EUR90 million with around 70 employees. All employees will on the closing date transfer to the new owner.
The sale of Euroresins is in line with the strategic actions DSM is pursuing for Composite Resins, as announced in November 2014.
Cathay Investments is the UK holding company for a group of companies engaged in chemical distribution and trading. Cathay’s principal trading business is Cathay Composites, which distributes glass fiber, resins and other composite materials throughout the UK and Scandinavia. Since its establishment Cathay has grown its portfolio to six companies.
As MRC wrote before, Royal DSM signed a partnership agreement with long fibre thermoplastic (LFT) specialist Plasticomp (Winona, Minnesota / USA) to develop bio-based LFT composite materials based on DSM’s "EcoPaXX" polyamide 4.10. The lightweight materials, which include compounds reinforced with glass fiber as well as carbon fiber, will be targeted at automotive and other performance-driven markets.
Royal DSM is a global science-based company active in health, nutrition and materials. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.
MRC